Tsang, K.Y.; Zaki, A.; Mavroukakis, S.A.; Arlen, P.M.; Fantini, M.
Affinity Maturation and Characterization of the Novel Monoclonal Antibody (mAb) PB-223 Targeting Cancer-Specific O-Glycans Terminating with α(2,6) Sialic Acids. Cancers 2026, 18, 2336.
https://doi.org/10.3390/cancers18142336
AMA Style
Tsang KY, Zaki A, Mavroukakis SA, Arlen PM, Fantini M.
Affinity Maturation and Characterization of the Novel Monoclonal Antibody (mAb) PB-223 Targeting Cancer-Specific O-Glycans Terminating with α(2,6) Sialic Acids. Cancers. 2026; 18(14):2336.
https://doi.org/10.3390/cancers18142336
Chicago/Turabian Style
Tsang, Kwong Y., Anjum Zaki, Sharon A. Mavroukakis, Philip M. Arlen, and Massimo Fantini.
2026. "Affinity Maturation and Characterization of the Novel Monoclonal Antibody (mAb) PB-223 Targeting Cancer-Specific O-Glycans Terminating with α(2,6) Sialic Acids" Cancers 18, no. 14: 2336.
https://doi.org/10.3390/cancers18142336
APA Style
Tsang, K. Y., Zaki, A., Mavroukakis, S. A., Arlen, P. M., & Fantini, M.
(2026). Affinity Maturation and Characterization of the Novel Monoclonal Antibody (mAb) PB-223 Targeting Cancer-Specific O-Glycans Terminating with α(2,6) Sialic Acids. Cancers, 18(14), 2336.
https://doi.org/10.3390/cancers18142336